Cover Image
市場調查報告書

生物晶片的全球市場:各國(美國、加拿大、印度、中國、日本、英國)、企業簡介、佔有率、趨勢、分析、機會、市場區隔及2015∼2021年的預測

Global Biochips Markets Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 346106
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
生物晶片的全球市場:各國(美國、加拿大、印度、中國、日本、英國)、企業簡介、佔有率、趨勢、分析、機會、市場區隔及2015∼2021年的預測 Global Biochips Markets Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022
出版日期: 2016年03月22日 內容資訊: 英文 140 Pages
簡介

全球生物晶片市場預計從2015年到2021年以年複合成長率18%擴大。現在生物晶片市場由於新用途的發現和現有技術的開發而急速擴大,不過,帶動這個成長的是個人化醫療市場擴大和政府支出的增加、醫療預算的投資、文明病的罹患率上升等。

本報告提供全球生物晶片市場相關調查、市場趨勢以及到2021年的收益預測與成長率、產業分析、競爭趨勢、各地區趨勢,及進入的主要企業簡介彙整。

第1章 簡介

第2章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 指標分析
  • 市場趨勢
  • 競爭情報
  • 價值鏈分析
  • 主要的購買標準
  • 策略性建議
  • 策略性結論

第3章 市場決策因素

  • 推動市場的要素
    • 個人化醫療的擴大
    • 政府及民間融資的擴大
    • 癌症診斷和治療的增加
    • 技術創新
    • 文明病和其他新疾病的增加
    • 技術進步
    • 醫療費的擴大
    • 大企業的研究開發
  • 阻礙市場的要素
    • 生物晶片的準確度不足誤導的分析
    • 藥物、醫療設備、蛋白質生物標記的翻譯率低
  • 市場課題
    • 生物晶片中診斷需要的經費高
    • 對於生物晶片市場引進的意識
  • 市場機會
    • 不久的將來,經濟試劑之創新的檢測技術將登場
    • 亞太地區的未開發地區有眼科藥品及設備市場的大幅可能性
    • 實驗室晶片技術的引進擴大

第4章 部門分析

第5章 市場區隔

  • 各用途
  • 各類型
  • 各終端用戶

第6章 競爭情報

  • 市場佔有率
  • 策略

第7章 各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第8章 企業分析

  • Agilent technologies
  • Affymetrix inc
  • Gene system inc
  • Agendia BV inc
  • Customarray inc
  • Digital genomics inc
  • Bio chain institute Inc
  • Biomerieux SA
  • Bio-rad laboratories inc
  • Cepheid Inc
  • Caliper life sciences inc
  • Cybrdi inc
  • EMD Millipore
  • Elim Biopharmaceuticals
  • Falcon Genomics.
  • Genalyte
  • Oxford gene technology
  • Wafergen biosystems inc
  • Predictive biosciences
  • Fluidigm corp
  • Gamida for life group
  • Illumina Inc
  • Life technologies corp
  • Origene technologies Inc
  • Perkinelmer inc
  • Roche nimblegen inc
  • Sequenom
  • Sigma aldrich corp
  • Imgenex
  • ISU ABXIS co. ltd
  • Quantalife inc

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HME-1371015

The global biochips market is anticipated to grow at a CAGR of 18.4 % during 2016 to 2022. The market has generated the revenue $7.63 Billion in 2016 and is anticipated to reach up to $ 17.65 Billion by 2022. The major driving forces for the market of biochips are Rise in diagnosis & treatment of cancer, Increase Government funding, Growth in personalized medicine and Technical advances.

In today's world the eczema and food allergies become the most common chronic non-communicable diseases in children in several courtesies.It is seen that more than 8% population are suffering from food allergy, globally in which approximately 6% aged 0-2 years have a food allergy Due to the increase in number of chronic cases such as asthma and multiple sclerosis and diseases like cancer and diabetes increased the demand of diagnosis globally which increased the market of biochip worldwide. According to world health organization in 2015 it has seen that in U.S. more than 1658370 new cancer cases had come in which more than 848200 male cancer cases are there and 810170 female cancer cases.

The global biochips market is segmented on the basis of applications and types. In applications the market is segmented by lab-on-chip (LOC) market, DNA micro array market and protein micro array. Based on types the market is segmented into protein microarray market and other array market DNA microarrays held the largest share segment of biochips market and is expected to holds the largest contributor in the period of 2015-2022.,be followed by lab-on-chip owing to its wide applications and increased adoption by various segments such as pharmaceutical , biotechnology, companies, and research laboratories and the protein microarrays will be the third largest due to advances in the fields of proteomics and genomics.

Geographically the market is segmented into North America, Europe, Asia-Pacific and Rest of World. North America dominates the global biochips market owing to large number of aging population and broad technical applications of biochips followed by Europe and Asia-Pacific. Asia-Pacific market will drive the growth of the market in future owing to growing economies like India and China.

Some of the major players of the market are Thermofisher, Agilent technologies Inc, Biochain institute Inc, Biomerieux sa, Bio-rad laboratories Inc, Caliper life sciences in, Cepheid In, Cybrdi Inc. Emd Millipore, Fluidigm corp, Gamida for life group, Illumina Inc, Imgenex, Life technologies corp, Origene technologies Inc. Acquisition, merger, innovation and new product launch are the major technologies which helps to sustain in the market. In 2016,thermofisher a US based company has announced that they had completed the acquisition of Affymetrix Inc, a US based company that provides cellular and genetic analytics products.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. MARKET SCOPE

2. MARKET OVERVIEW

  • 2.1. GLOBAL BIOCHIPS MARKET: EVOLUTION & TRANSITION
  • 2.2. INDUSTRY STRUCTURE
  • 2.3. MANUFACTURING PROCESS
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360 DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 FORCE MODEL
    • 2.7.4. SEE-SAW ANALYSIS
    • 2.7.5. PRICING ANALYSIS
    • 2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
    • 2.7.7. ROI ANALYSIS
    • 2.7.8. GAP ANALYSIS
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. KEY STRATEGIES AND ANALYSIS
    • 2.8.2. MARKET SHARE
    • 2.8.3. TOP COMPANY ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS & MARKET IMPACT
    • 3.1.1. RISE IN DIAGNOSIS & TREATMENT OF CANCER
    • 3.1.2. INCREASE GOVERNMENT FUNDING
    • 3.1.3. GROWTH IN PERSONALIZED MEDICINE
    • 3.1.4. TECHNICAL ADVANCES
  • 3.2. MARKET RESTRAINTS & MARKET IMPACT
    • 3.2.1. LACK OF HEALTHCARE COVERAGE RESTRICTS THE ADOPTION
    • 3.2.2. KNOWLEDGE CONSTRAINTS WITH RESPECT TO TECHNICAL KNOW-HOW
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. GROWTH OF MARKET IN THE SUB-CONTINENT OF ASIA
    • 3.3.2. WIDENING APPLICATIONS MARKET
  • 3.4. MARKET CHALLENGES
    • 3.4.1. COMPLEXITY OF BIOLOGICAL SYSTEMS
    • 3.4.2. UNCLEAR REGULATORY GUIDELINES
    • 3.4.3. HIGH INSTRUMENTATION COSTS

4. MARKET SEGMENTATION

  • 4.1. GLOBAL BIOCHIPS DNA MICROARRAY MARKET BY APPLICATION 2014-2022 ($ MILLION)
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION
      • 4.1.5.1. GENE EXPRESSION 2014-2022 ($ MILLION)
        • 4.1.5.1.1. APPLICATIONS
        • 4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.1.5. KEY CONCLUSIONS
      • 4.1.5.2. SNP GENOTYPE 2014-2022 ($ MILLION)
        • 4.1.5.2.1. APPLICATIONS
        • 4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.2.5. KEY CONCLUSIONS
      • 4.1.5.3. CANCER DIAGNOSIS & TREATMENT 2014-2022 ($ MILLION)
        • 4.1.5.3.1. APPLICATIONS
        • 4.1.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.3.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.1.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.3.5. KEY CONCLUSIONS
      • 4.1.5.4. GENOMICS 2014-2022 ($ MILLION)
        • 4.1.5.4.1. APPLICATIONS
        • 4.1.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.4.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.1.5.4.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.4.5. KEY CONCLUSIONS
      • 4.1.5.5. AGRICULTURAL BIOTECHNOLOGY 2014-2022 ($ MILLION)
        • 4.1.5.5.1. APPLICATIONS
        • 4.1.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.5.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.1.5.5.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.5.5. KEY CONCLUSIONS
      • 4.1.5.6. DRUG DISCOVERY 2014-2022 ($ MILLION)
        • 4.1.5.6.1. APPLICATIONS
        • 4.1.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.6.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.1.5.6.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.6.5. KEY CONCLUSIONS
      • 4.1.5.7. OTHERS 2014-2022 ($ MILLION)
        • 4.1.5.7.1. APPLICATIONS
        • 4.1.5.7.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.7.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.1.5.7.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.7.5. KEY CONCLUSIONS
  • 4.2. GLOBAL BIOCHIPS LAB ON CHIP/MICROFLUIDICS INDUSTRY BY APPLICATION 2014-2022 ($ MILLION)
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION
      • 4.2.5.1. HIGH THROUGHPUT SCREENING 2014-2022 ($ MILLION)
        • 4.2.5.1.1. APPLICATIONS
        • 4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.1.5. KEY CONCLUSIONS
      • 4.2.5.2. GENOMICS 2014-2022 ($ MILLION)
        • 4.2.5.2.1. APPLICATIONS
        • 4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.2.5. KEY CONCLUSIONS
      • 4.2.5.3. PROTEOMICS 2014-2022 ($ MILLION)
        • 4.2.5.3.1. APPLICATIONS
        • 4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.3.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.3.5. KEY CONCLUSIONS
      • 4.2.5.4. DRUG DISCOVERY 2014-2022 ($ MILLION)
        • 4.2.5.4.1. APPLICATIONS
        • 4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.4.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.2.5.4.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.4.5. KEY CONCLUSIONS
      • 4.2.5.5. IVD & POC 2014-2022 ($ MILLION)
        • 4.2.5.5.1. APPLICATIONS
        • 4.2.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.5.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.2.5.5.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.5.5. KEY CONCLUSIONS
      • 4.2.5.6. DIAGNOSTICS 2014-2022 ($ MILLION)
        • 4.2.5.6.1. APPLICATIONS
        • 4.2.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.6.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.2.5.6.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.6.5. KEY CONCLUSIONS
      • 4.2.5.7. OTHERS 2014-2022 ($ MILLION)
        • 4.2.5.7.1. APPLICATIONS
        • 4.2.5.7.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.7.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.2.5.7.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.7.5. KEY CONCLUSIONS
  • 4.3. GLOBAL BIOCHIPS MARKET BY PROTEIN MICRO ARRAY 2014-2022 ($ MILLION)
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION
      • 4.3.5.1. EXPRESSIONAL PROTEIN MICROARRAY 2014-2022 ($ MILLION)
        • 4.3.5.1.1. APPLICATIONS
        • 4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.1.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.1.5. KEY CONCLUSIONS
      • 4.3.5.2. FUNCTIONAL PROTEIN MICROARRAY 2014-2022 ($ MILLION)
        • 4.3.5.2.1. APPLICATIONS
        • 4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.2.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.2.5. KEY CONCLUSIONS
      • 4.3.5.3. REVERSE PHASE PROTEIN MICROARRAY 2014-2022 ($ MILLION)
        • 4.3.5.3.1. APPLICATIONS
        • 4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.3.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.3.5. KEY CONCLUSIONS
      • 4.3.5.4. EXPRESSION PROFILING 2014-2022 ($ MILLION)
        • 4.3.5.4.1. APPLICATIONS
        • 4.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.4.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.3.5.4.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.4.5. KEY CONCLUSIONS
      • 4.3.5.5. PROTEOMICS 2014-2022 ($ MILLION)
        • 4.3.5.5.1. APPLICATIONS
        • 4.3.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.5.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.3.5.5.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.5.5. KEY CONCLUSIONS
      • 4.3.5.6. DIAGNOSTICS 2014-2022 ($ MILLION)
        • 4.3.5.6.1. APPLICATIONS
        • 4.3.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.6.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.3.5.6.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.6.5. KEY CONCLUSIONS
      • 4.3.5.7. DRUG DISCOVERY 2014-2022 ($ MILLION)
        • 4.3.5.7.1. APPLICATIONS
        • 4.3.5.7.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.7.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.3.5.7.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.7.5. KEY CONCLUSIONS
      • 4.3.5.8. OTHERS 2014-2022 ($ MILLION)
        • 4.3.5.8.1. APPLICATIONS
        • 4.3.5.8.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.8.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
        • 4.3.5.8.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.8.5. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF M&A
    • 5.1.2. LIST OF JV
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIP
  • 5.2. TOP 10 COMPANY ANALYSIS - DASHBOARD

6. GLOBAL BIOCHIPS MARKET MARKET BY REGION (REVENUE ANALYSIS) 2014-2022 ($ MILLION)

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GEOGRAPHIC SEGMENTATION
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
          • 6.4.1.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.1.2.1.3. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.4. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
          • 6.4.1.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.1.2.2.3. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.4. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
          • 6.4.2.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.2.2.1.3. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.4. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
          • 6.4.2.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.2.2.2.3. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.4. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
          • 6.4.2.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.2.2.3.3. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.4. KEY CONCLUSIONS
        • 6.4.2.2.4. SPAIN
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
          • 6.4.2.2.4.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.2.2.4.3. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.4. KEY CONCLUSIONS
        • 6.4.2.2.5. ITALY
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
          • 6.4.2.2.5.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.2.2.5.3. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.4. KEY CONCLUSIONS
        • 6.4.2.2.6. REST OF EUROPE
          • 6.4.2.2.6.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
          • 6.4.2.2.6.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.2.2.6.3. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.6.4. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
          • 6.4.3.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.3.2.1.3. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.4. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
          • 6.4.3.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.3.2.2.3. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.4. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
          • 6.4.3.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.3.2.3.3. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.4. KEY CONCLUSIONS
        • 6.4.3.2.4. SOUTH KOREA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
          • 6.4.3.2.4.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.3.2.4.3. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.4. KEY CONCLUSIONS
        • 6.4.3.2.5. AUSTRALIA
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
          • 6.4.3.2.5.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.3.2.5.3. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.4. KEY CONCLUSIONS
        • 6.4.3.2.6. REST OF ASIA PACIFIC
          • 6.4.3.2.6.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
          • 6.4.3.2.6.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.3.2.6.3. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.6.4. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
          • 6.4.4.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.4.2.1.3. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.4. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
          • 6.4.4.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.4.2.2.3. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.4. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. AFFYMETRIX INC
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. KEY INNOVATION SECTOR
    • 7.1.4. STRATEGIC INITIATIVES
    • 7.1.5. SCOT ANALYSIS
  • 7.2. AGILENT TECHNOLOGIES INC
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. KEY INNOVATION SECTOR
    • 7.2.4. STRATEGIC INITIATIVES
    • 7.2.5. SCOT ANALYSIS
  • 7.3. BIOCHAIN INSTITUTE INC
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. KEY INNOVATION SECTOR
    • 7.3.4. STRATEGIC INITIATIVES
    • 7.3.5. SCOT ANALYSIS
  • 7.4. BIOMERIEUX SA
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. KEY INNOVATION SECTOR
    • 7.4.4. STRATEGIC INITIATIVES
    • 7.4.5. SCOT ANALYSIS
  • 7.5. BIO-RAD LABORATORIES INC
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. KEY INNOVATION SECTOR
    • 7.5.4. STRATEGIC INITIATIVES
    • 7.5.5. SCOT ANALYSIS
  • 7.6. CALIPER LIFE SCIENCES IN
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. KEY INNOVATION SECTOR
    • 7.6.4. STRATEGIC INITIATIVES
    • 7.6.5. SCOT ANALYSIS
  • 7.7. CEPHEID INC
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. KEY INNOVATION SECTOR
    • 7.7.4. STRATEGIC INITIATIVES
    • 7.7.5. SCOT ANALYSIS
  • 7.8. CYBRDI INC
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. KEY INNOVATION SECTOR
    • 7.8.4. STRATEGIC INITIATIVES
    • 7.8.5. SCOT ANALYSIS
  • 7.9. EMD MILLIPORE
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. KEY INNOVATION SECTOR
    • 7.9.4. STRATEGIC INITIATIVES
    • 7.9.5. SCOT ANALYSIS
  • 7.10. FLUIDIGM CORP
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. KEY INNOVATION SECTOR
    • 7.10.4. STRATEGIC INITIATIVES
    • 7.10.5. SCOT ANALYSIS
  • 7.11. GAMIDA FOR LIFE GROUP
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. KEY INNOVATION SECTOR
    • 7.11.4. STRATEGIC INITIATIVES
    • 7.11.5. SCOT ANALYSIS
  • 7.12. ILLUMINA INC
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. KEY INNOVATION SECTOR
    • 7.12.4. STRATEGIC INITIATIVES
    • 7.12.5. SCOT ANALYSIS
  • 7.13. IMGENEX
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. KEY INNOVATION SECTOR
    • 7.13.4. STRATEGIC INITIATIVES
    • 7.13.5. SCOT ANALYSIS
  • 7.14. LIFE TECHNOLOGIES CORP
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. KEY INNOVATION SECTOR
    • 7.14.4. STRATEGIC INITIATIVES
    • 7.14.5. SCOT ANALYSIS
  • 7.15. ORIGENE TECHNOLOGIES INC
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. KEY INNOVATION SECTOR
    • 7.15.4. STRATEGIC INITIATIVES
    • 7.15.5. SCOT ANALYSIS

LIST OF TABLES

  • 1. GLOBAL BIOCHIPS MARKET BY APPLICATION 2014-2022 ($ MILLION)
  • 2. GLOBAL GENE EXPRESSION BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 3. GLOBAL SNP GENOTYPE BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 4. GLOBAL BIOCHIPS MARKET IN CANCER DIAGNOSIS & TREATMENT BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 5. GLOBAL BIOCHIPS MARKET IN GENOMICS BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 6. GLOBAL BIOCHIPS MARKET IN AGRICULTURAL BIOTECHNOLOGY BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 7. GLOBAL BIOCHIPS MARKET IN DRUG DISCOVERY BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 8. GLOBAL BIOCHIPS MARKET MARKET IN OTHERS BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 9. GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY BY APPLICATION 2014-2022 ($ MILLION)
  • 10. GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY IN HIGH THROUGHPUT SCREENING BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 11. GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY IN GENOMICS BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 12. GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY IN PROTEOMICS BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 13. GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY IN DRUG DISCOVERY BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 14. GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY IN IVD & POC BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 15. GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY IN DIAGNOSTICS BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 16. GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY IN OTHERS BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 17. GLOBAL BIOCHIP PROTEIN MICRO ARRAY IN EXPRESSIONAL PROTEIN MICROARRAY BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 18. GLOBAL BIOCHIP PROTEIN MICRO ARRAY IN FUNCTIONAL PROTEIN MICROARRAY BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 19. GLOBAL BIOCHIP PROTEIN MICRO ARRAY IN REVERSE PHASE PROTEIN MICROARRAY BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 20. GLOBAL BIOCHIP PROTEIN MICRO ARRAY IN EXPRESSION PROFILING BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 21. GLOBAL BIOCHIP PROTEIN MICRO ARRAY IN PROTEOMICS BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 22. GLOBAL BIOCHIP PROTEIN MICRO ARRAY IN HIGH THROUGHPUT SCREENING BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 23. GLOBAL BIOCHIP PROTEIN MICRO ARRAY IN DIAGNOSTICS BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 24. GLOBAL BIOCHIP PROTEIN MICRO ARRAY IN DRUG DISCOVERY BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 25. GLOBAL BIOCHIP PROTEIN MICRO ARRAY IN OTHERS BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 26. NORTH AMERICA BIOCHIPS MARKET 2014-2022 ($ MILLION)
  • 27. EUROPE BIOCHIPS MARKET 2014-2022 ($ MILLION)
  • 28. ASIA PACIFIC BIOCHIPS MARKET 2014-2022 ($ MILLION)
  • 29. REST OF THE WORLD BIOCHIPS MARKET 2014-2022 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL BIOCHIP DNA MICROARRAY INDUSTRY BY GENE EXPRESSION 2014-2022 ($ MILLION)
  • 2. GLOBAL BIOCHIP DNA MICROARRAY INDUSTRY BY SNP GENOTYPE 2014-2022 ($ MILLION)
  • 3. GLOBAL BIOCHIP DNA MICROARRAY INDUSTRY BY CANCER DIAGNOSIS & TREATMENT 2014-2022 ($ MILLION)
  • 4. GLOBAL BIOCHIP DNA MICROARRAY INDUSTRY BY GENOMICS 2014-2022 ($ MILLION)
  • 5. GLOBAL BIOCHIP DNA MICROARRAY INDUSTRY BY AGRICULTURAL BIOTECHNOLOGY 2014-2022 ($ MILLION)
  • 6. GLOBAL BIOCHIP DNA MICROARRAY INDUSTRY BY DRUG DISCOVERY 2014-2022 ($ MILLION)
  • 7. GLOBAL BIOCHIP DNA MICROARRAY INDUSTRY BY OTHERS 2014-2022 ($ MILLION)
  • 8. GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY BY HIGH THROUGHPUT SCREENING 2014-2022 ($ MILLION)
  • 9. GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY BY GENOMICS 2014-2022 ($ MILLION)
  • 10. GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY BY PROTEOMICS 2014-2022 ($ MILLION)
  • 11. GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY BY DRUG DISCOVERY 2014-2022 ($ MILLION)
  • 12. GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY BY IVD & POC 2014-2022 ($ MILLION)
  • 13. GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY BY DIAGNOSTICS 2014-2022 ($ MILLION)
  • 14. GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY BY OTHERS 2014-2022 ($ MILLION)
  • 15. GLOBAL BIOCHIP PROTEIN MICRO ARRAY MARKET BY EXPRESSIONAL PROTEIN MICROARRAY 2014-2022 ($ MILLION)
  • 16. GLOBAL BIOCHIP PROTEIN MICRO ARRAY MARKET BY FUNCTIONAL PROTEIN MICROARRAY 2014-2022 ($ MILLION)
  • 17. GLOBAL BIOCHIP PROTEIN MICRO ARRAY MARKET BY REVERSE PHASE PROTEIN MICROARRAY 2014-2022 ($ MILLION)
  • 18. GLOBAL BIOCHIP PROTEIN MICRO ARRAY MARKET BY EXPRESSION PROFILING 2014-2022 ($ MILLION)
  • 19. GLOBAL BIOCHIP PROTEIN MICRO ARRAY MARKET BY PROTEOMICS 2014-2022 ($ MILLION)
  • 20. GLOBAL BIOCHIP PROTEIN MICRO ARRAY MARKET BY HIGH THROUGHPUT SCREENING 2014-2022 ($ MILLION)
  • 21. GLOBAL BIOCHIP PROTEIN MICRO ARRAY MARKET BY DIAGNOSTICS 2014-2022 ($ MILLION)
  • 22. GLOBAL BIOCHIP PROTEIN MICRO ARRAY MARKET BY DRUG DISCOVERY 2014-2022 ($ MILLION)
  • 23. GLOBAL BIOCHIP PROTEIN MICRO ARRAY MARKET BY OTHERS 2014-2022 ($ MILLION)
  • 24. UNITED STATES (U.S.) BIOCHIPS MARKET 2014-2022 ($ MILLION)
  • 25. CANADA BIOCHIPS MARKET 2014-2022 ($ MILLION)
  • 26. UNITED KINGDOM (UK) BIOCHIPS MARKET 2014-2022 ($ MILLION)
  • 27. FRANCE BIOCHIPS MARKET 2014-2022 ($ MILLION)
  • 28. GERMANY BIOCHIPS MARKET 2014-2022 ($ MILLION)
  • 29. SPAIN BIOCHIPS MARKET 2014-2022 ($ MILLION)
  • 30. ITALY BIOCHIPS MARKET 2014-2022 ($ MILLION)
  • 31. ROE BIOCHIPS MARKET 2014-2022 ($ MILLION)
  • 32. INDIA BIOCHIPS MARKET 2014-2022 ($ MILLION)
  • 33. CHINA BIOCHIPS MARKET 2014-2022 ($ MILLION)
  • 34. JAPAN BIOCHIPS MARKET 2014-2022 ($ MILLION)
  • 35. KOREA BIOCHIPS MARKET 2014-2022 ($ MILLION)
  • 36. AUSTRALIA BIOCHIPS MARKET 2014-2022 ($ MILLION)
  • 37. ROAPAC BIOCHIPS MARKET 2014-2022 ($ MILLION)
  • 38. LATIN AMERICA BIOCHIPS MARKET 2014-2022 ($ MILLION)
  • 39. MENA BIOCHIPS MARKET 2014-2022 ($ MILLION)
Back to Top